Skip to content
Screener

DexCom DXCM Equity Method Investments

Equity Method Investments at other companies

Applied Materials logo
Applied MaterialsAMAT
$5.14B+41.3%
CMS
CMS EnergyCMS
$65M-8.5%
Southern Company logo
Southern CompanySO
$1.37B—
Edison International logo
Edison InternationalEIX
$4.52B+5.4%
Lennar logo
LennarLEN
$114.4M-14.3%
Lowe's Companies logo
Lowe's CompaniesLOW
$247M-17.7%

Other financials

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$33.08B+8.3%
Enterprise value$32.07B+8.7%
P/E33.1×-20.3×
P/S6.7×-0.4×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0×0.0×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The source filing: DexCom’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 5:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001093557-26-000073

The carrying values of our non-marketable equity investments were $219.5 million as of March 31, 2026 and $218.0 million as of December 31, 2025. During the three months ended March 31, 2026 and March 31, 2025, we did not record any upward adjustments.

Item 1. Financial Statements

FAQ

What is DexCom's equity method investments?
DexCom (DXCM) reported equity method investments of $219.5M in Q1 2026.
How has DexCom's equity method investments changed year-over-year?
DexCom's equity method investments increased by 89.6% year-over-year, from $115.8M to $219.5M.
What is the long-term trend for DexCom's equity method investments?
Over 3 years (2022 to 2025), DexCom's equity method investments has grown at a 125.5% compound annual growth rate (CAGR), from $19M to $218M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.

Ask your AI about DexCom's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude